2Coiling J. An update on the AHCPR guideline implementation. Nurse Practice Forum, 1994,5 : 134-137.
3McGuire EJ, Bennett CJ, Konnak JA, et al. Experience with pubovaginal slings for urinary incontinence at the university of Michigan. J Urol, 1987,138:525-529.
4Buckner S ,Milicic I ,Daza A ,et al. ABT-866 ,a novel alpha(1A) -adrenoceptor agonist with antagonist properties at the alpha ( 1B )- andalpha ( 1 D) -adrenoceptor subtypes. Eur J Pharmacol, 2002,449 : 159-165.
5Brune ME, O' Neill AB, Gauvin DM, et al. Comparison of alpha 1-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models. J Urol,2001,166 : 1555-1559.
6Nito H. Clinical effect of midodfine hydrochlofide on the patients with urinary incontinence. Hinyokika Kiyo, 1994,40:91-94.
7Weil EH,Eerdmans PH, Dijkman GA, et al. Randomized double-blind placebo-controlled muhicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase Ⅱ study. Int Urogynecol J Pelvic FloorDvsfunct, 1998,9 : 145-150.
